Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
68 studies found for:    "male pattern baldness" OR "Androgenetic Alopecia"
Show Display Options
Rank Status Study
21 Completed A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995)
Conditions: Androgenetic Alopecia;   Male Pattern Baldness;   Female Pattern Baldness
Intervention: Biological: Autologous cultured dermal and epidermal cells
22 Completed A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541)
Conditions: Androgenetic Alopecia;   Male Pattern Baldness;   Female Pattern Baldness
Intervention: Biological: Autologous cultured dermal and epidermal cells
23 Completed A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012)
Conditions: Androgenetic Alopecia;   Male Pattern Baldness;   Female Pattern Baldness
Intervention: Biological: Autologous cultured dermal and epidermal cells
24 Completed A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669)
Conditions: Androgenetic Alopecia;   Male Pattern Baldness;   Female Pattern Baldness
Intervention: Biological: Autologous cultured dermal and epidermal cells
25 Completed A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931)
Conditions: Androgenetic Alopecia;   Male Pattern Baldness;   Female Pattern Baldness
Intervention: Biological: Autologous cultured mixed population of dermal cells
26 Completed A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy
Condition: Androgenetic Alopecia
Interventions: Device: Handi-Dome Laser;   Device: Incandescent red light source.
27 Recruiting Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention: Device: topical 5% Minoxidil (Microneedling)
28 Completed
Has Results
Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Drug: 1mg Finasteride active;   Drug: 0.02mg dutasteride;   Drug: 0.1mg dutasteride;   Drug: 0.5mg dutasteride;   Drug: Finasteride placebo;   Drug: Dutasteride placebo
29 Not yet recruiting Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Device: PRGF-Endoret;   Other: Saline Solution
30 Completed A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males
Condition: Androgenetic Alopecia
Interventions: Device: X5 HairLaser;   Device: X5 Hair Laser Sham Device
31 Unknown  A Study to Determine the Safety and Efficacy of Autologous Human Platelet Lysate for Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Biological: Autologous Human Platelet Lysate (HPL);   Other: 2 % Minoxidil and /or Finasteride
32 Completed Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Drug: Minoxidil;   Drug: vehicle of 5% Minoxidil topical foam
33 Unknown  Study To Determine Safety & Efficacy Of Autologous Human Platelet Lysate in Androgenetic Alopecia After Hair Transplant
Condition: Androgenetic Alopecia
Interventions: Biological: Autologous Human Platelet Lysate;   Other: Standard hair follicle transplant
34 Recruiting A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)
Condition: Androgenetic Alopecia
Interventions: Drug: SM04554;   Drug: Vehicle
35 Recruiting A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Drug: CB-03-01 solution;   Drug: Minoxidil Solution 5%;   Drug: Placebo solution
36 Unknown  Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
Condition: Androgenetic Alopecia
Intervention: Drug: tetrapeptide aldehyde proteasome inhibitor (NEOSH101)
37 Completed Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
Condition: Androgenetic Alopecia
Intervention: Drug: tetrapeptide aldehyde proteasome inhibitor (NEOSH101)
38 Completed Microarray Analysis of Scalp Biopsies After Minoxidil Treatment
Condition: Androgenetic Alopecia
Interventions: Drug: Minoxidil;   Other: Placebo
39 Completed
Has Results
Clinical Trial in Females for Female Pattern Hair Loss
Condition: Androgenetic Alopecia
Interventions: Drug: 5% Minoxidil Topical Foam;   Drug: Vehicle Topical Foam
40 Recruiting Efficacy of Nutrition Supplement for Treatment of Men With Hair Loss
Condition: Androgenetic Alopecia
Interventions: Dietary Supplement: HCap Formula;   Dietary Supplement: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years